IRIS
MATALUNI, GIORGIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.508
AS - Asia 1.896
EU - Europa 1.695
SA - Sud America 270
Continente sconosciuto - Info sul continente non disponibili 209
AF - Africa 24
OC - Oceania 4
Totale 13.606
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.427
SG - Singapore 885
IT - Italia 721
CN - Cina 260
BR - Brasile 224
RU - Federazione Russa 216
KR - Corea 177
HK - Hong Kong 163
VN - Vietnam 151
IE - Irlanda 148
DE - Germania 122
GB - Regno Unito 100
UA - Ucraina 94
BD - Bangladesh 88
FR - Francia 75
NL - Olanda 61
JP - Giappone 55
CA - Canada 47
FI - Finlandia 35
IN - India 31
SE - Svezia 22
AT - Austria 19
TR - Turchia 16
AR - Argentina 14
CH - Svizzera 14
IQ - Iraq 14
ES - Italia 11
PL - Polonia 11
RO - Romania 11
ZA - Sudafrica 11
CO - Colombia 10
ID - Indonesia 8
TT - Trinidad e Tobago 7
CL - Cile 6
CZ - Repubblica Ceca 6
MX - Messico 6
KG - Kirghizistan 5
MY - Malesia 5
PH - Filippine 5
PK - Pakistan 5
PY - Paraguay 5
UZ - Uzbekistan 5
BE - Belgio 4
EC - Ecuador 4
JM - Giamaica 4
LU - Lussemburgo 4
AL - Albania 3
AU - Australia 3
DK - Danimarca 3
EG - Egitto 3
HN - Honduras 3
IR - Iran 3
LB - Libano 3
MA - Marocco 3
PE - Perù 3
SA - Arabia Saudita 3
SV - El Salvador 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BG - Bulgaria 2
BS - Bahamas 2
DZ - Algeria 2
HR - Croazia 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
NI - Nicaragua 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
LT - Lituania 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 13.400
Salva come PNG Salva come JPEG
Città #
Wilmington 2.269
Houston 1.990
Woodbridge 1.801
Singapore 489
Ashburn 411
San Jose 285
Chandler 262
Fairfield 176
New York 164
Hong Kong 159
Dublin 137
Ann Arbor 112
Beijing 100
Rome 96
Santa Clara 90
Medford 87
Council Bluffs 78
Seattle 73
Cambridge 72
Los Angeles 67
Milan 61
The Dalles 55
Dearborn 54
Ho Chi Minh City 54
Jacksonville 49
Tokyo 49
Lawrence 41
Moscow 40
Dallas 39
Hanoi 38
Lauterbourg 38
Buffalo 34
São Paulo 34
North Bergen 29
Turin 21
Naples 20
Redondo Beach 20
Nuremberg 17
Piove di Sacco 17
Roebling 17
San Diego 17
Atlanta 16
Bologna 15
Munich 15
Florence 14
Palo Alto 14
London 12
Seoul 12
Denver 11
Montreal 11
Palermo 11
Toronto 11
Orem 10
Verona 10
Lappeenranta 9
San Francisco 9
Amsterdam 8
Creede 8
Helsinki 8
Redwood City 8
Vienna 8
Basingstoke 7
Chicago 7
Haiphong 7
Istanbul 7
Manchester 7
Paris 7
Salt Lake City 7
Warsaw 7
Chennai 6
Columbus 6
Elk Grove Village 6
Lodi 6
Mülheim 6
Norwalk 6
Phoenix 6
Boston 5
Brooklyn 5
Chengdu 5
Da Nang 5
Kilburn 5
Menlo Park 5
Philadelphia 5
Tooting 5
Vicenza 5
Ankara 4
Belo Horizonte 4
Bergamo 4
Boardman 4
Bogotá 4
Brno 4
Carrboro 4
Chaguanas 4
Cincinnati 4
Engelhard 4
Erbil 4
Frankfurt am Main 4
Guangzhou 4
Inverigo 4
Jakarta 4
Totale 10.085
Salva come PNG Salva come JPEG
Nome #
Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies 507
Central and peripheral nervous system involvement as a manifestation of graft versus host disease after liver transplantation: case report 483
Acute disseminated encephalomyelitis following Campylobacter jejuni gastroenteritis: Case report and review of the literature 477
IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy 476
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 474
International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome 467
EPIDEMIOLOGY AND POTENTIAL PROGNOSTIC FACTORS IN GUILLAIN-BARRE SYNDROME: TEN-YEAR EXPERIENCE OF "POLICLINICO TOR VERGATA" 461
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 441
Bickerstaff encephalitis with anti gm1-antibodies relapsing as guillain-barre syndrome: a case report 432
Bickerstaff encephalitis: report of two atypical cases with negative anti GQ1B antibodies 425
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 419
Autonomic nervous system involvement in patients with chronic dysimmune neuropathies 406
Meningomyeloradiculitis mimicking recurrent bilateral neuralgic amyotrophy. 398
A multicentric cohort study on anti-mag antibodies neuropathy: does response to rituximab differ depending on the associated hematological disease? 390
High dose intravenous immunoglobulin is effective in painful diabetic polyneuropathy resistant to conventional treatments: results of a double blind, randomized, placebo-controlled, multicenter trial 385
Motor unit number estimation in 30 patients with chronic dysimmune neuropathies 374
Neuroretinal dysfunction is associated with early peripheral motor unit loss in type 1 diabetes 352
Regional variation of Guillain-Barré syndrome 341
Miscarriage induces reactivation of inflammation in relapsing-remitting multiple sclerosis 335
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 333
Atypical CIDP: diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 321
Neuroretinal Dysfunction Is Associated with Early Peripheral Motor Unit Loss in Type 1 Diabetes Mellitus 308
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND ANTI-CONTACTIN-ASSOCIATED PROTEIN-1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 271
Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus 271
PREVALENCE OF ANTI-NEUROFASCIN-155, ANTI-CONTACTIN-1 AND CONTACTIN-ASSOCIATED PROTEIN 1 ANTIBODIES IN CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A SEROLOGICAL MULTICENTER STUDY IN ITALY 254
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 229
Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis 200
Current treatment practice of Guillain-Barré syndrome 175
Anti-HBs titers are not decreased after treatment with oral Cladribine in patients with Multiple Sclerosis vaccinated against Hepatitis B virus 168
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 165
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 165
Assessment of macular function by multifocal electroretinogram in patients with multiple sclerosis treated with fingolimod 151
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 143
Complex Rearrangement of the Entire Retinal Posterior Pole in Patients with Relapsing Remitting Multiple Sclerosis 136
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 135
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 132
Correction to: Validity of the Italian multiple sclerosis neuropsychological screening questionnaire 125
Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells' Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration 119
Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey 114
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 111
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 104
Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection 97
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 93
The neurophysiological lesson from the Italian CIDP database 92
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 84
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 84
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 83
null 81
Structural and Functional Assessment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes Without History of Optic Neuropathy 81
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 77
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 74
MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study 73
COVID-19 vaccine hesitancy among Italian people with multiple sclerosis 73
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 70
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 65
Topographical Correlation between Structural and Functional Impairment of the Macular Inner Retinal Layers in Multiple Sclerosis Eyes with a History of Optic Neuropathy 61
Impact of environmental factors and physical activity on disability and quality of life in CIDP 61
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values 61
Response to Dr. Wee 54
High-Dose Intravenous Immunoglobulin Is Effective in Painful Diabetic Polyneuropathy Resistant to Conventional Treatments. Results of a Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial 53
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 13
null 3
Totale 13.606
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.842
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022357 0 0 0 38 24 42 13 19 32 38 28 123
2022/2023851 53 58 100 125 59 159 89 38 79 5 62 24
2023/2024376 62 12 26 22 29 60 27 11 23 22 3 79
2024/20251.448 45 298 155 106 69 130 64 69 164 134 126 88
2025/20262.240 150 92 267 133 219 54 378 227 256 194 171 99
2026/20271.008 118 100 416 374 0 0 0 0 0 0 0 0
Totale 13.606